Company records / entradatx.com

Entrada Therapeutics

Entrada Therapeutics (entradatx.com): 4 changes recorded in its website history since October 2018. Homepage last checked 6 November 2026.

Recorded changes

Newest observations first. Each interval bounds when the website changed; it is not an exact event date.

HeadlineBetween 18 July 2025 and 15 July 2026
BeforeMaking Intracellular Therapeutics A Reality
AfterMeet Max, living with Duchenne Muscular Dystrophy
Observed on the company’s website; business claims are not independently verified.
earlier archived page later archived page Link to observation
HiringBetween 29 October 2018 and 20 July 2019
Added a careers page.
Observed on the company’s website; business claims are not independently verified.
earlier archived page later archived page Link to observation
HeadlineBetween 29 October 2018 and 20 July 2019
BeforeEntrada Therapeutics is building the leading intracellular biologics company to transform the treatment of devastating diseases
AfterMaking Intracellular Biologics a Reality
Observed on the company’s website; business claims are not independently verified.
earlier archived page later archived page Link to observation
FundingBetween 29 October 2018 and 20 July 2019
Announced on its homepage: “Read more March 19, 2019 Entrada Therapeutics Raises $59 Million Series A to Advance Intracellular Biologics Platform December 18, 2018 B…”.
Observed on the company’s website; business claims are not independently verified.
earlier archived page later archived page Link to observation

First recorded website

Observed 29 October 2018

Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.

How it described itself

Entrada Therapeutics is building the leading intracellular biologics company to transform the treatment of devastating diseases

archived page Link to first observation

All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.

How it describes itself

Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.

July 2026 – November 2026 · 2 captures · latest observed messagingMeet Max, living with Duchenne Muscular Dystrophy
Overcoming the challenge of intracellular target access to transform the treatment of devastating diseases.
This wording observed 6 November 2026.
current websiteHistorical capture not publicly available
Inspect 2 captures in this group
- 15 July 2026 · Meet Max, living with Duchenne Muscular Dystrophy archived page
- 6 November 2026 · Meet Max, living with Duchenne Muscular Dystrophy current websiteHistorical capture not publicly available
October 2018 – July 2025 · 7 capturesMaking Intracellular Therapeutics A Reality
Overcoming the challenge of intracellular target access to transform the treatment of devastating diseases.
This wording observed 18 July 2025.
archived page
Inspect 7 captures in this group
- 29 October 2018 · Entrada Therapeutics is building the leading intracellular biologics company to transform the treatment of devastating diseases archived page
- 20 July 2019 · Making Intracellular Biologics a Reality archived page
- 27 January 2022 · Making Intracellular Therapeutics A Reality archived page
- 12 January 2023 · Making Intracellular Therapeutics A Reality archived page
- 5 January 2024 · Making Intracellular Therapeutics A Reality archived page
- 9 July 2024 · Making Intracellular Therapeutics A Reality archived page
- 18 July 2025 · Making Intracellular Therapeutics A Reality archived page

Cite this record

StartupHistory, “Entrada Therapeutics” company record, https://startuphistory.org/c/entradatx.com

Machine-readable: /c/entradatx.com.json. How changes are found: method.